Related Experiment Videos
Expression of corticosteroid-binding globulin mRNA in human uterine endometrial cancers
R Misao1, Y Nakanishi, J Fujimoto
1Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
Abstract:
Since it has been demonstrated that corticosteroid-binding globulin (CBG) plays a role in intracellar steroidal actions in target cells, the expression of CBG mRNA as the measure of CBG expression was investigated in human endometrial cancers in order to assess the biological implications of CBG. The level of CBG mRNA was analyzed using competitive reverse transcription-polymerase chain reaction-Southern blot analysis. While the level of CBG mRNA was significantly (P < 0.01) higher in secretory phase endometrium than in early and late proliferative phase endometrium, the level of CBG mRNA tended to decrease with advanced dedifferentiation of endometrial cancers as compared to normal endometrium. These results suggest that dedifferentiation of endometrial cancers induces a reduction in intracellular CBG synthesis.
Insights
Corticosteroid-binding globulin (CBG) mRNA levels are higher in the secretory phase endometrium. In endometrial cancers, CBG mRNA expression decreases with dedifferentiation, suggesting reduced intracellular CBG synthesis.
Area of Science:
- Endocrinology
- Molecular Biology
- Gynecologic Oncology
Background:
- Corticosteroid-binding globulin (CBG) is implicated in intracellular steroid hormone action.
- Understanding CBG's role in endometrial physiology and pathology is crucial.
Purpose of the Study:
- To investigate the expression of CBG mRNA in human endometrial cancers.
- To assess the biological implications of CBG in endometrial cancer development and progression.
Main Methods:
- CBG mRNA expression was quantified using competitive reverse transcription-polymerase chain reaction-Southern blot analysis.
- Endometrial tissue samples from different phases of the menstrual cycle and varying grades of endometrial cancer were analyzed.
Main Results:
- CBG mRNA levels were significantly higher in secretory phase endometrium compared to proliferative phase endometrium (P < 0.01).
- A trend of decreasing CBG mRNA levels was observed in advanced dedifferentiated endometrial cancers relative to normal endometrium.
Conclusions:
- Endometrial dedifferentiation in cancer is associated with reduced intracellular CBG synthesis.
- CBG expression may serve as a potential biomarker for endometrial cancer progression.